is medvi tirzepatide fda approved approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Did you know? Medi-Weightloss® providers

It might just become your new fave

During this time, avoid swallowing as much as possible

Follow-up consultations are required every six months for active patients, or every nine months if you have reached maintenance dosing

Its an FDA-approved treatment gaining attention for its potential to help individuals achieve long-term weight loss

At AgeRejuvenation, we do not prescribe unapproved or compounded versions, a caution that echoes the FDA's own warning about products that have not been tested for safety or quality

[1] Patients with diabetes and pre-existing retinopathy should be monitored for worsening retinopathy during rapid improvement in glycemic control